Should TrimSpa X32 Remain on the Market? An analysis of TrimSpa X32’s compliance with FDA and FTC guidelines

DSpace/Manakin Repository

Should TrimSpa X32 Remain on the Market? An analysis of TrimSpa X32’s compliance with FDA and FTC guidelines

Show simple item record

dc.contributor.advisor Hutt, Peter Barton en_US
dc.contributor.author Sitron, Neil en_US
dc.date.accessioned 2012-12-07T15:01:34Z
dc.date.issued 2005 en_US
dc.identifier.citation Should TrimSpa X32 Remain on the Market? (2005 Third Year Paper) en
dc.identifier.uri http://nrs.harvard.edu/urn-3:HUL.InstRepos:10015264
dc.description.abstract TrimSpa X32 has launched onto the dietary supplement and weight loss markets with a deluge of promotion, from a celebrity endorser to a million dollar contest, from sponsorship of award shows to a website filled with information, testimonials, and a personal consultation tool. But is the product safe and are the advertisements for the product truthful and nonmisleading? This paper examines TrimSpa X32 to determine whether it complies with the applicable regulatory guidelines of both the United States Food and Drug Administration (FDA) and United States Federal Trade Commission (FTC). In order to do so, this paper first analyses the Dietary Health and Supplement Act of 1994 which provides the basis for FDA regulations and “Dietary Supplements: An Advertising Guide for Industry” which sets out guidelines to aid the FTC in regulating the advertising of dietary supplements and also provides a comprehensive guide to advertisers to aid them in complying with FTC regulations. This paper concludes that TrimSpa currently complies with all applicable regulations. However, there are several issues which may arise in the future, including safety and efficacy concerns and potential claims of misleading advertisements and duty-to-warn litigation. en
dc.language.iso en_US en
dash.license LAA en_US
dc.subject Food and Drug Law en
dc.subject weight loss en
dc.subject dietary supplement en
dc.title Should TrimSpa X32 Remain on the Market? An analysis of TrimSpa X32’s compliance with FDA and FTC guidelines en
dc.type Paper (for course/seminar/workshop) en_US
dc.date.available 2012-12-07T15:01:34Z

Files in this item

Files Size Format View
Sitron05.pdf 182.6Kb PDF View/Open
Sitron05.rtf 106.4Kb RTF file View/Open
Sitron05.html 60.32Kb HTML View/Open

This item appears in the following Collection(s)

Show simple item record

 
 

Search DASH


Advanced Search
 
 

Submitters